Deutsche Bank AG Acquires 89,851 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Deutsche Bank AG grew its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 39.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 316,205 shares of the biotechnology company’s stock after acquiring an additional 89,851 shares during the quarter. Deutsche Bank AG owned 0.41% of Axon Enterprise worth $187,927,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of AXON. Capital World Investors boosted its position in shares of Axon Enterprise by 86.4% during the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company’s stock worth $1,079,145,000 after buying an additional 841,772 shares during the period. Alliancebernstein L.P. boosted its position in Axon Enterprise by 273.8% during the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company’s stock worth $659,128,000 after acquiring an additional 812,337 shares during the last quarter. Norges Bank bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $482,081,000. GQG Partners LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $478,349,000. Finally, Vanguard Group Inc. lifted its position in shares of Axon Enterprise by 3.4% in the fourth quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company’s stock worth $5,019,886,000 after purchasing an additional 275,959 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Down 0.3 %

Axon Enterprise stock opened at $684.59 on Friday. The company’s 50-day moving average price is $564.50 and its two-hundred day moving average price is $583.86. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The stock has a market cap of $53.29 billion, a P/E ratio of 176.90, a P/E/G ratio of 5.17 and a beta of 1.24. Axon Enterprise, Inc. has a twelve month low of $273.52 and a twelve month high of $715.99.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.07. Axon Enterprise had a return on equity of 7.50% and a net margin of 15.37%. The business had revenue of $603.63 million during the quarter, compared to analysts’ expectations of $585.67 million. During the same period last year, the firm posted $1.15 EPS. The firm’s revenue for the quarter was up 31.3% compared to the same quarter last year. As a group, analysts expect that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Insider Activity

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. The trade was a 0.33 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.40% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several brokerages have issued reports on AXON. Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. The Goldman Sachs Group increased their price target on Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, Needham & Company LLC boosted their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Thursday. One analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $640.91.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.